Drugs / RFUSIN2-AML1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00718250 | May 2008 → May 2011 | acute myeloid leukemia | King's College Hospital NHS Trust | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RFUSIN2-AML1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00718250 ↗ |
| Modality | Vaccine | “'AML Cell Vaccine'” NCT00718250 ↗ |